Curt I. Civin

University of Maryland, Baltimore — United States

Medicine · Health Sciences

56h-index11.9kcitations306works3.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(58), Hematopoietic Stem Cell Transplantation(49), Chronic Myeloid Leukemia Treatments(31), Immune Cell Function and Interaction(30), Acute Lymphoblastic Leukemia research(26)

Publications306 total

Xenotransplantation of Pancreatic Islets with MMP-9-Enhanced Human Mesenchymal Stem Cells for the Treatment of Type 1 Diabetes in Mice
American Journal of Transplantation·2026
Augmenting the Anti‐Leukemic Activity of the BCL‐2 Inhibitor Venetoclax Through Its Transformation Into Polypharmacologic Dual BCL‐2/HDAC1 and Dual BCL‐2/HDAC6 Inhibitors
Drug Development Research·2025· 4 citedOpen Access
The polypharmacy combination of the BCL-2 inhibitor venetoclax (VEN) and the FLT3 inhibitor gilteritinib (GIL) is more active in acute myeloid leukemia cells than novel polypharmacologic BCL-2/FLT3 VEN–GIL hybrid single-molecule inhibitors
European Journal of Medicinal Chemistry·2024· 6 cited
Roles of MicroRNAs in Hematologic Malignancies
WORLD SCIENTIFIC eBooks·2023· 1 cited
ART714 is a best-in-class antileukemic 2-carbon-linked dimeric artemisinin derivative
Cancer Chemotherapy and Pharmacology·2023
FIGURE S1 from c-MYC Generates Repair Errors via Increased Transcription of Alternative-NHEJ Factors, LIG3 and PARP1, in Tyrosine Kinase–Activated Leukemias
2023Open Access
FIGURE S4 from c-MYC Generates Repair Errors via Increased Transcription of Alternative-NHEJ Factors, LIG3 and PARP1, in Tyrosine Kinase–Activated Leukemias
2023Open Access
Data from c-MYC Generates Repair Errors via Increased Transcription of Alternative-NHEJ Factors, LIG3 and PARP1, in Tyrosine Kinase–Activated Leukemias
2023Open Access
FIGURE S3 from c-MYC Generates Repair Errors via Increased Transcription of Alternative-NHEJ Factors, LIG3 and PARP1, in Tyrosine Kinase–Activated Leukemias
2023Open Access
Table S1 from c-MYC Generates Repair Errors via Increased Transcription of Alternative-NHEJ Factors, LIG3 and PARP1, in Tyrosine Kinase–Activated Leukemias
2023Open Access
Table S1 from c-MYC Generates Repair Errors via Increased Transcription of Alternative-NHEJ Factors, LIG3 and PARP1, in Tyrosine Kinase–Activated Leukemias
2023Open Access
Data from c-MYC Generates Repair Errors via Increased Transcription of Alternative-NHEJ Factors, LIG3 and PARP1, in Tyrosine Kinase–Activated Leukemias
2023Open Access
Table S3 from c-MYC Generates Repair Errors via Increased Transcription of Alternative-NHEJ Factors, LIG3 and PARP1, in Tyrosine Kinase–Activated Leukemias
2023Open Access
Table S2 from c-MYC Generates Repair Errors via Increased Transcription of Alternative-NHEJ Factors, LIG3 and PARP1, in Tyrosine Kinase–Activated Leukemias
2023Open Access
FIGURE S4 from c-MYC Generates Repair Errors via Increased Transcription of Alternative-NHEJ Factors, LIG3 and PARP1, in Tyrosine Kinase–Activated Leukemias
2023Open Access
FIGURE S3 from c-MYC Generates Repair Errors via Increased Transcription of Alternative-NHEJ Factors, LIG3 and PARP1, in Tyrosine Kinase–Activated Leukemias
2023Open Access
Table S3 from c-MYC Generates Repair Errors via Increased Transcription of Alternative-NHEJ Factors, LIG3 and PARP1, in Tyrosine Kinase–Activated Leukemias
2023Open Access
FIGURE S2 from c-MYC Generates Repair Errors via Increased Transcription of Alternative-NHEJ Factors, LIG3 and PARP1, in Tyrosine Kinase–Activated Leukemias
2023Open Access
FIGURE S1 from c-MYC Generates Repair Errors via Increased Transcription of Alternative-NHEJ Factors, LIG3 and PARP1, in Tyrosine Kinase–Activated Leukemias
2023Open Access
Table S2 from c-MYC Generates Repair Errors via Increased Transcription of Alternative-NHEJ Factors, LIG3 and PARP1, in Tyrosine Kinase–Activated Leukemias
2023Open Access
page 1 of 16Next →

Frequent Co-authors

Xiaobing Yu(5), Linzhao Cheng(5), Matthew Malehorn(4), Robert W. Georgantas(4), Shelly Heimfeld(4), Saul J. Sharkis(4), Yaddanapudi Ravindranath(4), Jonathan K. Alder(3), Stephen B. Baylin(3), K Sawada(3), C. Philip Steuber(3), Bruce M. Camitta(3), Kara Scheibner(3), Alan D. Friedman(3), Jonathan J. Shuster(3), Richard Hildreth(2), Sebastien Morisot(2), Jean‐Pierre J. Issa(2), Michael I. Collector(2), Sanford B. Krantz(2)